X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (250) 250
infectious diseases (183) 183
male (145) 145
female (139) 139
index medicus (133) 133
hiv (128) 128
adult (125) 125
virology (120) 120
hiv infections - drug therapy (105) 105
immunology (101) 101
hiv infections - virology (94) 94
hiv-1 - genetics (86) 86
middle aged (86) 86
antiretroviral therapy (81) 81
hiv-1 (73) 73
human immunodeficiency virus--hiv (63) 63
viral load (61) 61
medicin och hälsovetenskap (60) 60
hiv infection (56) 56
microbiology (56) 56
infection (55) 55
infektionsmedicin (55) 55
anti-hiv agents - therapeutic use (53) 53
drug resistance (50) 50
drug therapy (50) 50
hiv-1 - drug effects (50) 50
medical and health sciences (48) 48
hiv infections - immunology (46) 46
therapy (45) 45
aids (44) 44
rna, viral - blood (44) 44
infectious medicine (43) 43
antiviral agents (41) 41
molecular sequence data (41) 41
research (41) 41
antiretroviral drugs (40) 40
genotype (40) 40
mutation (40) 40
klinisk medicin (39) 39
research article (39) 39
health aspects (38) 38
human immunodeficiency virus (38) 38
medicine (38) 38
drug-resistance (37) 37
cd4 lymphocyte count (36) 36
hiv-1 - isolation & purification (36) 36
sweden (36) 36
analysis (35) 35
hiv infections - epidemiology (35) 35
infections (35) 35
immunodeficiency-virus type-1 (32) 32
transmission (32) 32
acquired immune deficiency syndrome--aids (31) 31
highly active antiretroviral therapy (31) 31
hiv-1 - classification (30) 30
hiv-1 - immunology (28) 28
phylogeny (28) 28
rna (28) 28
anti-hiv agents - pharmacology (27) 27
clinical medicine (27) 27
cohort studies (27) 27
europe (27) 27
treatment outcome (27) 27
base sequence (26) 26
human-immunodeficiency-virus (26) 26
multidisciplinary sciences (26) 26
science (26) 26
viruses (26) 26
drug resistance, viral (25) 25
epidemiology (25) 25
aged (24) 24
disease progression (23) 23
hiv-1 - physiology (23) 23
polymerase chain reaction (23) 23
acquired immune deficiency syndrome (22) 22
adolescent (22) 22
care and treatment (22) 22
mutations (22) 22
patients (22) 22
prevalence (22) 22
resistance (22) 22
aids/hiv (21) 21
antiretroviral agents (21) 21
virus diseases (21) 21
medicinska och farmaceutiska grundvetenskaper (20) 20
protease inhibitors (20) 20
time factors (20) 20
amino acid sequence (19) 19
cd4 antigen (19) 19
lymphocytes (19) 19
treatment failure (19) 19
drug resistance, viral - genetics (18) 18
hepacivirus - genetics (18) 18
individuals (18) 18
reverse transcriptase inhibitors - therapeutic use (18) 18
risk factors (18) 18
cd4-positive t-lymphocytes - immunology (17) 17
hiv infections - transmission (17) 17
t cells (17) 17
young adult (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, Scandinavian journal of infectious diseases., Volume 106., 109
Book
PLoS ONE, ISSN 1932-6203, 09/2016, Volume 11, Issue 9, p. e0162503
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 06/2016, Volume 16, Issue 1, p. 305
Journal Article
PLoS Pathogens, ISSN 1553-7366, 2014, Volume 10, Issue 7, p. e1004251
Journal Article
Retrovirology, ISSN 1742-4690, 01/2013, Volume 10, Issue 1, pp. 7 - 7
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0178942
Introduction Antiretroviral therapy (ART) has been successfully introduced in low-middle income countries. However an increasing rate of ART failure with... 
VIRAL LOAD | AFRICA | VIROLOGICAL FAILURE | PERFORMANCE | MULTIDISCIPLINARY SCIENCES | ADULTS | SWITCH | CHILDREN | Humans | Male | Nevirapine - therapeutic use | Monitoring, Physiologic | HIV-1 - growth & development | Clinical Decision-Making | Stavudine - therapeutic use | Treatment Failure | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | pol Gene Products, Human Immunodeficiency Virus - genetics | Emtricitabine - therapeutic use | Cross-Sectional Studies | Tenofovir - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Computational Biology | Tanzania | Genotype | HIV-1 - genetics | Benzoxazines - therapeutic use | HIV-1 - classification | Antiretroviral Therapy, Highly Active | Atazanavir Sulfate - therapeutic use | Drug Resistance, Viral - genetics | HIV Infections - drug therapy | Lopinavir - therapeutic use | Viral Load - drug effects | Prevention | Antiviral agents | Care and treatment | Analysis | DNA polymerases | Dosage and administration | Research | Drug resistance | Drug therapy | HIV infection | Drugs | Therapy | Load distribution | RNA-directed DNA polymerase | Nevirapine | Cross-resistance | Medical services | Switches | Income | Viruses | Stavudine | Criteria | Efavirenz | Accumulation | Guidelines | Gene sequencing | Fragmentation | Tenofovir | Disease resistance | Immunology | Salvage | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Bioinformatics | Monitoring | Failure | Deoxyribonucleic acid--DNA | Emtricitabine | Antiretroviral drugs | Sensitivity analysis | Lopinavir | Lamivudine | Antiretroviral therapy | Amplification | Sensitivity | Algorithms | Inhibitors | Genotyping | Abacavir | Mutation | DNA sequencing | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33484
Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may contribute to failure of antiretroviral treatment. The prevalence of... 
VIRAL LOAD | MAXIMUM-LIKELIHOOD | TRANSMISSION | RECOMMENDATIONS | BIOLOGY | SURVEILLANCE | ANTIRETROVIRAL THERAPY | MUTATIONS | SWITZERLAND | TYPE-1 | SUBTYPE-B | Anti-HIV Agents - pharmacology | Prevalence | HIV Infections - epidemiology | Humans | Middle Aged | Drug Resistance, Viral | Child, Preschool | Infant | Male | Phylogeny | Young Adult | RNA, Viral - genetics | Homosexuality, Male | Time Factors | HIV Infections - diagnosis | Polymerase Chain Reaction | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Child | HIV-1 - drug effects | HIV Infections - virology | CD4 Lymphocyte Count | HIV-1 - genetics | Mutation - genetics | Sweden - epidemiology | HIV-1 - classification | Adolescent | Aged | Highly active antiretroviral therapy | Antiviral agents | Medical research | Disease transmission | Analysis | Medicine, Experimental | Drug resistance | HIV (Viruses) | Health aspects | Epidemiology | Cluster analysis | Laboratories | Viruses | Infections | Gene sequencing | Sexually transmitted diseases | Acquired immune deficiency syndrome--AIDS | Consent | Antiretroviral agents | Human immunodeficiency virus--HIV | Drug therapy | Antiretroviral drugs | Multidrug resistance | Regression analysis | Clustering | Patients | CD4 antigen | Studies | Cohort analysis | Infectious diseases | Hospitals | Surveillance | Mutation | Microbiology in the medical area | Mikrobiologi inom det medicinska området | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0180140
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 01/2017, Volume 17, Issue 1, p. 37
Journal Article